サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1414161

ダイエットピルの世界市場レポート 2024年

Diet Pills Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ダイエットピルの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

ダイエットピルの市場規模は近年急速に拡大しています。2023年の16億2,000万米ドルから2024年には18億1,000万米ドルへと、CAGR11.5％で拡大します。過去の期間に観察された成長は、健康とフィットネスに対する意識の高まり、肥満率の上昇、ライフスタイルと食事パターンの変化、効果的なマーケティングとプロモーション戦略、医学的推奨と処方など、さまざまな要因に起因しています。

慢性疾患の有病率の増加は、ダイエットピル市場の成長を促進すると予想されます。慢性疾患は、1年以上続き、継続的な医学的治療を必要とする状態や病気を特徴とするため、包括的な管理アプローチが必要となります。このようなアプローチには、バランスの取れた食事、定期的な身体活動、行動の変化など、生活習慣の改善がしばしば含まれます。2023年1月現在、米国の国立医学図書館（National Library of Medicine）のデータによると、少なくとも1つの慢性疾患を持つ50歳以上の高齢者は、2050年までに1億4,266万人に増加すると予測されています。慢性疾患の有病率の上昇は、結果としてダイエットピル市場の成長に寄与します。

2023年のダイエットピル市場で最大の地域は北米です。ダイエットピル市場レポートの対象地域は、アジア太平洋,西欧,東欧,北米,南米,中東,アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018～2023年
  • 市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界のダイエットピル市場、製品タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 処方
  • OTC
  • ハーブサプリメント
  • 世界のダイエットピル市場、年齢別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ティーンエイジャー
  • 大人
  • 世界のダイエットピル市場、流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • ドラッグストア
  • 世界のダイエットピル市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 食欲の抑制
  • 脂肪の抑制
  • その他

第7章 地域および国の分析

  • 世界のダイエットピル市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界のダイエットピル市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ダイエットピル市場の競合情勢
  • ダイエットピル市場の企業プロファイル
    • GlaxoSmithKline plc
    • Iovate Health Sciences International Inc.
    • Novo Nordisk A/S
    • Gelesis Inc.
    • VIVUS Inc.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r11671

“Diet Pills Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diet pills market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diet pills? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The diet pills market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product Type: Prescription; Over The Counter; Herbal Supplements
  • 2) By Age: Teenagers; Adults
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Drug Stores
  • 4) By Application: Appetite Suppression; Fat Blocking; Other Applications
  • Companies Mentioned: GlaxoSmithKline plc; Iovate Health Sciences International Inc.; Novo Nordisk A/S; Gelesis Inc.; VIVUS Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Diet pills, in the context of weight management, are tablets or capsules designed to aid users in reducing or controlling their weight. These pills are formulated to enhance metabolism, reduce appetite, and facilitate the breakdown of fat.

The primary categories of diet pill products include prescription, over-the-counter, and herbal supplements. A prescription is a written authorization from a doctor for access to a medication that cannot be obtained without such approval. Prescription diet pills are typically recommended by healthcare professionals due to the potential risks and dangers associated with misuse or abuse of these medications. These pills are utilized by teenagers and adults and are available through various channels such as hospital pharmacies, retail pharmacies, online pharmacies, and drug stores. They are applied for purposes such as appetite suppression, fat blocking, and other weight management objectives.

The diet pills market research report is one of a series of new reports from The Business Research Company that provides diet pills market statistics, including diet pills industry global market size, regional shares, competitors with a diet pills market share, detailed diet pills market segments, market trends and opportunities, and any further data you may need to thrive in the diet pills industry. This diet pills market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diet pills market size has grown rapidly in recent years. It will grow from $1.62 billion in 2023 to $1.81 billion in 2024 at a compound annual growth rate (CAGR) of 11.5%. The growth observed during the historic period can be attributed to various factors, including increased awareness of health and fitness, rising obesity rates, changes in lifestyles and dietary patterns, effective marketing and promotion strategies, and medical endorsements and prescriptions.

The diet pills market size is expected to see rapid growth in the next few years. It will grow to $2.79 billion in 2028 at a compound annual growth rate (CAGR) of 11.4%. The anticipated growth in the forecast period can be attributed to a sustained focus on health and wellness, a global increase in the overweight population, the expansion of weight management services, innovations in formulations and ingredients, and the growing prevalence of e-commerce and direct-to-consumer channels. Major trends expected in the forecast period include technological innovations in formulations, an emphasis on mental well-being, the incorporation of appetite suppressants, the integration of digital health solutions, and the expansion of online and e-commerce distribution channels.

The escalating issue of obesity is anticipated to drive the growth of the diet pill market in the future. Obesity, characterized by abnormal or excessive weight gain, typically with a body mass index (BMI) exceeding 30, poses significant health risks. It increases the likelihood of various cancers, including those affecting the esophagus, colon, rectum, liver, gallbladder, pancreas, and kidneys. Additionally, obesity is associated with the development of disorders such as type 2 diabetes (T2D) and cardiovascular diseases (CVD). Individuals struggling with obesity often turn to diet pills as a form of medication to aid in weight loss by reducing appetite and food cravings. For instance, as of May 2022, data from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) revealed that more than 2 in 5 adults (42.4%) have obesity, with approximately 1 in 11 adults (9.2%) experiencing severe obesity. Consequently, the increasing prevalence of obesity is a significant driver for the growth of the diet pill market.

The implementation of various initiatives is expected to contribute to the growth of the diet pills market. Initiatives involve specific actions, projects, or programs undertaken to achieve particular goals or address specific issues. One example is the initiative taken by Currax Pharmaceuticals LLC, a US-based specialty biopharmaceutical company and the manufacturer of the oral weight loss medication brand CONTRAVE (naltrexone HCl/bupropion HCl). In August 2022, the company launched a new campaign called "One Size Does Not Fit All," aiming to highlight the unique challenges faced by individuals dealing with overweight or obesity. The campaign emphasizes the necessity of a personalized approach to weight loss for long-term success. Therefore, the increasing adoption of initiatives is a driving force behind the growth of the diet pills market.

The increasing prevalence of chronic diseases is expected to drive the growth of the diet pills market. Chronic diseases, characterized by conditions or illnesses that last for more than a year and require ongoing medical treatment, necessitate comprehensive management approaches. These approaches often involve lifestyle modifications, such as adopting a balanced diet, engaging in regular physical activity, and making behavioral changes. As of January 2023, data from the National Library of Medicine, a US-based agency, suggests that the number of people in the US aged 50 and older with at least one chronic condition is projected to increase to 142.66 million by 2050. The rising prevalence of chronic diseases will consequently contribute to the growth of the diet pills market.

The popularity of plant-based supplements emerges as a key trend in the diet pill market, with companies developing plant-based diet pills to maintain their market positions. For instance, in April 2022, Wellbeing Nutrition, an India-based plant-based nutrition company, launched SLOW, a formulation consisting of 13 supplements catering to various health and wellness needs, including reproductive support, bone health, weight loss, and daily multivitamins. The SLOW technology employs continuous-release coated pellets in a capsule to ensure the timely digestion of vitamins and nutrients throughout the day. This new line is designed to meet consumer demands for increased energy, physical endurance, mental alertness, and functional health benefits for disease prevention.

In November 2022, Audax Private Equity, a US-based middle-market investment company, acquired Medi-Weightloss, Inc. for an undisclosed amount. Through this acquisition, Medi-Weightloss expanded access to care for an underserved and growing patient population. Medi-Weightloss is a US-based company that provides specialized weight-loss programs addressing obesity and associated ailments, including the provision of weight loss and diet pills.

Major companies operating in the diet pills market report are GlaxoSmithKline plc, Iovate Health Sciences International Inc., Novo Nordisk A/S, Gelesis Inc., VIVUS Inc., Pfizer Inc., Zoller India Pvt. Ltd., Creative Biosciences Pvt. Ltd., Applied Nutrition Ltd. (India), Herbalife Nutrition India Private Limited, Camillotek India Pvt. Ltd., Avon Products Inc., NOW Foods, MuscleTech Research and Development LLC, Healthviva Group of Companies, Nalpropion Pharmaceuticals LLC, Chong's Health Care Pte. Ltd., Currax Pharmaceuticals LLC, TEVA PHARMACEUTICAL INDUSTRIES Ltd., Eli Lilly and Company, Arena Pharmaceuticals GmbH & Co. KG, Orexigen Therapeutics Inc., Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Roche Holding AG, Sanofi SA, Boehringer Ingelheim International GmbH, Merck & Co. Inc., Johnson & Johnson, Abbott Laboratories

North America was the largest region in the diet pills market in 2023. The regions covered in the diet pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the diet pills market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The diet pills market consists of sales of xenical, qsymia, saxenda, diethylpropion, liraglutide, and phentermine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Diet Pills Market Characteristics

3. Diet Pills Market Trends And Strategies

4. Diet Pills Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Diet Pills Market Size and Growth

  • 5.1. Global Diet Pills Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Diet Pills Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Diet Pills Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Diet Pills Market Segmentation

  • 6.1. Global Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Prescription
  • Over The Counter
  • Herbal Supplements
  • 6.2. Global Diet Pills Market, Segmentation By Age, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Teenagers
  • Adults
  • 6.3. Global Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
  • 6.4. Global Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Appetite Suppression
  • Fat Blocking
  • Other Applications

7. Diet Pills Market Regional And Country Analysis

  • 7.1. Global Diet Pills Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Diet Pills Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Diet Pills Market

  • 8.1. Asia-Pacific Diet Pills Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Diet Pills Market

  • 9.1. China Diet Pills Market Overview
  • 9.2. China Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Diet Pills Market

  • 10.1. India Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Diet Pills Market

  • 11.1. Japan Diet Pills Market Overview
  • 11.2. Japan Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Diet Pills Market

  • 12.1. Australia Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Diet Pills Market

  • 13.1. Indonesia Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Diet Pills Market

  • 14.1. South Korea Diet Pills Market Overview
  • 14.2. South Korea Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Diet Pills Market

  • 15.1. Western Europe Diet Pills Market Overview
  • 15.2. Western Europe Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Diet Pills Market

  • 16.1. UK Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Diet Pills Market

  • 17.1. Germany Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Diet Pills Market

  • 18.1. France Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Diet Pills Market

  • 19.1. Italy Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Diet Pills Market

  • 20.1. Spain Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Diet Pills Market

  • 21.1. Eastern Europe Diet Pills Market Overview
  • 21.2. Eastern Europe Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Diet Pills Market

  • 22.1. Russia Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Diet Pills Market

  • 23.1. North America Diet Pills Market Overview
  • 23.2. North America Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Diet Pills Market

  • 24.1. USA Diet Pills Market Overview
  • 24.2. USA Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Diet Pills Market

  • 25.1. Canada Diet Pills Market Overview
  • 25.2. Canada Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Diet Pills Market

  • 26.1. South America Diet Pills Market Overview
  • 26.2. South America Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Diet Pills Market

  • 27.1. Brazil Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Diet Pills Market

  • 28.1. Middle East Diet Pills Market Overview
  • 28.2. Middle East Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Diet Pills Market

  • 29.1. Africa Diet Pills Market Overview
  • 29.2. Africa Diet Pills Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Diet Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Diet Pills Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Diet Pills Market Competitive Landscape And Company Profiles

  • 30.1. Diet Pills Market Competitive Landscape
  • 30.2. Diet Pills Market Company Profiles
    • 30.2.1. GlaxoSmithKline plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Iovate Health Sciences International Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Novo Nordisk A/S
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Gelesis Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. VIVUS Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Diet Pills Market Competitive Benchmarking

32. Global Diet Pills Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Diet Pills Market

34. Diet Pills Market Future Outlook and Potential Analysis

  • 34.1 Diet Pills Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Diet Pills Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Diet Pills Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer